A man living in rural western Thailand presented with a well-demarcated pinkish plaque on the dorsal surface of the right hand, extending to several fingers ([Figure 1](#F1){ref-type="fig"}). Mild scale was present. The lesion was not pruritic or tender, and there was no sporotrichoid lymphadenopathy. The differential diagnosis included cutaneous deep fungal and atypical mycobacterial infections. A punch biopsy showed a mononuclear dermal infiltrate with multinucleated giant cells and scattered dark-brown, round sclerotic bodies resembling "copper pennies" ([Figure 2](#F2){ref-type="fig"}), features consistent with chromoblastomycosis, a cutaneous deep fungal infection. Oral terbinafine (anti-fungal sterol inhibitor) was administered at 250 mg two times daily for 2 weeks and then, 250 mg daily for 14 weeks, with progressive resolution.

![Well-demarcated plaque on the dorsal surface of hand. This figure appears in color at [www.ajtmh.org](www.ajtmh.org).](tropmed-83-448-g001){#F1}

![Histology shows mononuclear cell infiltrate and a dark-brown, round sclerotic body resembling a "copper penny" (arrow), consistent with chromoblastomycosis (hematoxylin-eosin stain; 1,000×). This figure appears in color at [www.ajtmh.org](www.ajtmh.org).](tropmed-83-448-g002){#F2}

Chromoblastomycosis, caused by a saprophytic pigmented (dematiaceous) fungus, occurs in many tropical areas, including Thailand.[@R1] It may be acquired by traumatic implantation, such as a wood splinter contaminated with fungal elements. Regional lymphatic damage and malignant transformation may occur. Treatment options include oral anti-fungal medications and physical methods, the former often requiring lengthy courses, and responses vary.[@R1],[@R2] Here, we speculate that terbinafine dosed at 500 mg daily for the first 2 weeks, a less commonly prescribed higher daily dose, may have been beneficial.
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